Showing results (11-20 of 528) with videos related to

Sort By:
Pageof 53
Waste Management (New York, N.Y.)|March 18, 2006
Participation in curbside recycling schemes and its variation with material typesR Woodard, M K Harder, M Bench
Environmental Management|February 18, 2006
Two measured parameters correlated to participation rates in curbside recycling schemes in the UKMarie K Harder, Ryan Woodard, Matthew L Bench
Protein Science : a Publication of the Protein Society|January 1, 1995
High-sensitivity determination of tyrosine-phosphorylated peptides by on-line enzyme reactor and electrospray ionization mass spectrometryL N Amankwa, K Harder, F Jirik, et al.
The Science of the Total Environment|December 11, 2019
A values-based approach for generating localized social indicators for use in sustainability assessment and decision-making: Test case of brownfield soft reuse in NigeriaElijah C Odii, Chike C Ebido, Marie K Harder
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 29, 2023
INvestigation of the impact of a Pharmacist in a Hospital At Home Care Team (IN PHACT)Morgan E Patrick, Curtis K Harder, Sean P Spina
Canadian Family Physician Medecin De Famille Canadien|August 16, 2011
Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary careBrian E Grunau, Matthew O Wiens, Kenneth K Harder
Waste Management (New York, N.Y.)|March 14, 2007
Development of a new quality fair access best value performance indicator (BVPI) for recycling servicesM K Harder, N Stantzos, R Woodard, et al.
BMC Veterinary Research|May 26, 2020
Computed tomographic features of the prostatic gland in neutered and intact dogsN Kuhnt, L K Harder, I Nolte, et al.
Cardiovascular Drugs and Therapy|April 1, 1992
Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal functionK J Osterziel, R Dietz, K Harder, et al.
The Canadian Journal of Hospital Pharmacy|October 20, 2015
Pharmacists' Perceptions of the Influence of Interactions with the Pharmaceutical Industry on Clinical Decision-MakingAaron M Tejani, Peter Loewen, Richard Bachand, et al.
Pageof 53